These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6173688)

  • 41. [Protection of cells by nucleoside transport inhibitor combined with nebularine and the therapeutic effect on transplantable mouse tumors].
    Fu NW
    Zhonghua Zhong Liu Za Zhi; 1985 Mar; 7(2):94-8. PubMed ID: 3874052
    [No Abstract]   [Full Text] [Related]  

  • 42. Antitumor effects of RNA isolated from murine tumors and embryos.
    Pottathil R; Meier H
    Cancer Res; 1977 Sep; 37(9):3280-6. PubMed ID: 577892
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical use of interferon and its inducers].
    Nosik NN; Ershov FI
    Antibiotiki; 1980 Sep; 25(9):695-710. PubMed ID: 6158289
    [No Abstract]   [Full Text] [Related]  

  • 44. Effect of exogenous interferon treatment on mouse mammary tumors.
    Came PE; Moore DH
    J Natl Cancer Inst; 1972 Apr; 48(4):1151-4. PubMed ID: 4336879
    [No Abstract]   [Full Text] [Related]  

  • 45. Interferon therapy in experimental Semliki forest virus disease in mice.
    Jain C; Madan AR; Babbar OP
    Indian J Med Res; 1983 Nov; 78():726-31. PubMed ID: 6200435
    [No Abstract]   [Full Text] [Related]  

  • 46. The relationship between cytotoxicity and interferon induction in L-M strain mouse fibroblasts.
    Asculai SS; Kuchler RJ
    Proc Soc Exp Biol Med; 1973 May; 143(1):252-5. PubMed ID: 4703439
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of interferon inducers and interferon on bacterial infections.
    Giron DJ; Schmidt JP; Ball RJ; Pindak FF
    Antimicrob Agents Chemother; 1972 Jan; 1(1):80-1. PubMed ID: 4670434
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of interferon treatment on the tumour-specific antibody response of BALB-c mice infected with Rauscher virus.
    Tóth FD; Váczi L; Berencsi C
    Acta Microbiol Acad Sci Hung; 1971; 18(2):109-12. PubMed ID: 4337368
    [No Abstract]   [Full Text] [Related]  

  • 49. [The medical significance of interferons and their inducers].
    Ershov FI
    Vestn Ross Akad Med Nauk; 2004; (2):9-13. PubMed ID: 15101201
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Quantitative determination of the effect of antineoplastic agents].
    Brius VR
    Probl Gematol Pereliv Krovi; 1975 Jul; 20(7):33-8. PubMed ID: 1197231
    [No Abstract]   [Full Text] [Related]  

  • 51. Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors.
    Corbett TH; Griswold DP; Mayo JG; Laster WR; Schabel FM
    Cancer Res; 1975 Jun; 35(6):1568-73. PubMed ID: 1131824
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sensitivity of target cells to the cytotoxic effects of lymphocytes induced by interferon.
    Slavina EG; Leneva NV; Svet-Moldavsky GJ
    Folia Biol (Praha); 1974; 20(4):231-7. PubMed ID: 4370360
    [No Abstract]   [Full Text] [Related]  

  • 53. [Inhibitory effect of combined administration of neuraminidase and interferon in mice with Rauscher leukemia].
    Kobrinskiĭ GD; Barinskiĭ IF; Efimova IV; Eremian LK
    Biull Eksp Biol Med; 1982 Jan; 93(1):62-4. PubMed ID: 6175365
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interferon options.
    Br Med J; 1977 Jan; 1(6053):64-5. PubMed ID: 832014
    [No Abstract]   [Full Text] [Related]  

  • 55. [Experimental research to clinical application of interferons].
    Imamishi J; Tanaka A
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):53-9. PubMed ID: 6198966
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glucan:inhibition of tumor growth and enhancement of survival in four syngeneic murine tumor models.
    Di Luzio NR; McNamee R; Browder WI; Williams D
    Cancer Treat Rep; 1978 Nov; 62(11):1857-66. PubMed ID: 728903
    [No Abstract]   [Full Text] [Related]  

  • 57. Inhibition of spontaneous mammary carcinoma of mice by treatment with interferon and poly I:C.
    Came PE; Moore DH
    Proc Soc Exp Biol Med; 1971 May; 137(1):304-5. PubMed ID: 4325777
    [No Abstract]   [Full Text] [Related]  

  • 58. Interferons and interferon inducers: development of clinical usefulness and therapeutic promise.
    Pollard RB
    Drugs; 1982; 23(1-2):37-55. PubMed ID: 6173188
    [No Abstract]   [Full Text] [Related]  

  • 59. The effect of high doses of poly(I).poly(C) induced mouse L cell interferon on Rauscher leukemia virus induced erythroleukemia in BALB/c mice.
    Hekman RA; Prins ME; Bosveld IJ; Trapman J
    Int J Cancer; 1981; 27(4):493-500. PubMed ID: 6168593
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Brief communication: Cure of murine leukemia with drug and interferon treatment.
    Chirigos MA; Pearson JW
    J Natl Cancer Inst; 1973 Oct; 51(4):1367-8. PubMed ID: 4745868
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.